Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

November 29, 2026

Study Completion Date

January 1, 2027

Conditions
Artery Coronary Stenosis
Interventions
DEVICE

Percutaneous Coronary Intervention

The Vivo ISAR is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease.

Trial Locations (19)

13005

RECRUITING

CHU La Timone, Marseille

13015

NOT_YET_RECRUITING

Hopital Nord, Marseille

13100

RECRUITING

Clinique Axium, Aix-en-Provence

14000

NOT_YET_RECRUITING

CHU CAEN, Caen

31076

NOT_YET_RECRUITING

Clinique Pasteur, Toulouse

31400

RECRUITING

Chu Toulouse, Toulouse

44277

RECRUITING

Hôpital Privé du Confluent, Nantes

51000

RECRUITING

CHU Reims, Reims

54271

RECRUITING

Clinique Louis Pasteur, Essey-lès-Nancy

65013

RECRUITING

CH de Bigorre, Tarbes

67091

NOT_YET_RECRUITING

CHRU Strasbourg, Strasbourg

67500

RECRUITING

CH Haguenau, Haguenau

68003

RECRUITING

Hôpital A. Schweitzer - GHCA, Colmar

75013

NOT_YET_RECRUITING

APHP, Paris

76000

RECRUITING

Clinique Saint Hilaire, Rouen

82000

NOT_YET_RECRUITING

Clinique Pont de Chaume, Montauban

83190

RECRUITING

Polyclinique Les Fleurs, Ollioules

91300

RECRUITING

HP Jacques Cartier, Massy

91480

NOT_YET_RECRUITING

HP Claude Galien, Quincy-sous-Sénart

All Listed Sponsors
collaborator

EVAMED

OTHER

lead

Translumina GmbH

INDUSTRY